Dr.  

Johan K Wallman

, Sweden


Presentations

Secukinumab provides sustained improvement in signs and symptoms of psoriatic arthritis in patients with and without enthesitis: 2 year pooled analysis of two Phase 3 studies  09 October 2019 00:00 - 00:00

Abstracts

Secukinumab provides sustained improvement in signs and symptoms of psoriatic arthritis in patients with and without enthesitis: 2 year pooled analysis of two Phase 3 studies  Psoriasis More